These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 33881274)

  • 1. Looking back from 2020, how cannabis use and related behaviours changed in Canada.
    Rotermann M
    Health Rep; 2021 Apr; 32(4):3-14. PubMed ID: 33881274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What has changed since cannabis was legalized?
    Rotermann M
    Health Rep; 2020 Feb; 31(2):11-20. PubMed ID: 32073644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of trends in the prevalence of cannabis use and related metrics in Canada.
    Rotermann M
    Health Rep; 2019 Jun; 30(6):3-13. PubMed ID: 31216047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Too young for Cannabis? Choice of minimum legal age for legalized non-medical Cannabis in Canada.
    Nguyen HV; Bornstein S; Gamble JM; Mathews M; Bishop L; Mital S
    BMC Public Health; 2020 May; 20(1):557. PubMed ID: 32404144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and forms of cannabis use in legal vs. illegal recreational cannabis markets.
    Goodman S; Wadsworth E; Leos-Toro C; Hammond D;
    Int J Drug Policy; 2020 Feb; 76():102658. PubMed ID: 31927413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of legalization of access to recreational Cannabis on Canadian medical users with Cancer.
    Hawley P; Gobbo M; Afghari N
    BMC Health Serv Res; 2020 Oct; 20(1):977. PubMed ID: 33109169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabis use and patterns among middle and older aged Canadians prior to legalization: a sex-specific analysis of the Canadian Tobacco, Alcohol and Drugs Survey.
    Keethakumar A; Mehra VM; Khanlou N; Tamim H
    BMC Public Health; 2021 Jan; 21(1):26. PubMed ID: 33407292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in California cannabis exposures following recreational legalization and the COVID-19 pandemic.
    Roth W; Tam M; Bi C; Kim J; Lewis J; Ho R; Apollonio DE
    Clin Toxicol (Phila); 2022 May; 60(5):632-638. PubMed ID: 34871128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabis use for symptom relief in multiple sclerosis: A cross-sectional survey of webinar attendees in the US and Canada.
    Hildebrand A; Minnier J; Cameron MH
    Mult Scler Relat Disord; 2020 Feb; 38():101516. PubMed ID: 31855842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Legalizing and Regulating Marijuana in Canada: Review of Potential Economic, Social, and Health Impacts.
    Hajizadeh M
    Int J Health Policy Manag; 2016 Aug; 5(8):453-456. PubMed ID: 27694657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An overview of select cannabis use and supply indicators pre- and post-legalization in Canada.
    Fischer B; Lee A; Robinson T; Hall W
    Subst Abuse Treat Prev Policy; 2021 Oct; 16(1):77. PubMed ID: 34620191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Legal sourcing of ten cannabis products in the Canadian cannabis market, 2019-2021: a repeat cross-sectional study.
    Wadsworth E; Rynard V; Driezen P; Freeman TP; Rychert M; Wilkins C; Hall W; Gabrys R; Hammond D
    Harm Reduct J; 2023 Feb; 20(1):19. PubMed ID: 36803833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impacts of potency, warning messages, and price on preferences for Cannabis flower products.
    Shi Y; Cao Y; Shang C; Pacula RL
    Int J Drug Policy; 2019 Dec; 74():1-10. PubMed ID: 31382201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Availability, retail price and potency of legal and illegal cannabis in Canada after recreational cannabis legalisation.
    Mahamad S; Wadsworth E; Rynard V; Goodman S; Hammond D
    Drug Alcohol Rev; 2020 May; 39(4):337-346. PubMed ID: 32291811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perceived access to cannabis and ease of purchasing cannabis in retail stores in Canada immediately before and one year after legalization.
    Wadsworth E; Driezen P; Chan G; Hall W; Hammond D
    Am J Drug Alcohol Abuse; 2022 Mar; 48(2):195-205. PubMed ID: 35157544
    [No Abstract]   [Full Text] [Related]  

  • 16. Triangulating web & general population surveys: Do results match legal cannabis market sales?
    Caulkins JP; Davenport S; Doanvo A; Furlong K; Siddique A; Turner M; Kilmer B
    Int J Drug Policy; 2019 Nov; 73():293-300. PubMed ID: 31272752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Community-level policy responses to state marijuana legalization in Washington State.
    Dilley JA; Hitchcock L; McGroder N; Greto LA; Richardson SM
    Int J Drug Policy; 2017 Apr; 42():102-108. PubMed ID: 28365192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reasons for Purchasing Cannabis From Illegal Sources in Legal Markets: Findings Among Cannabis Consumers in Canada and U.S. States, 2019-2020.
    Goodman S; Wadsworth E; Hammond D
    J Stud Alcohol Drugs; 2022 May; 83(3):392-401. PubMed ID: 35590180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabis flower prices and transitions to legal sources after legalization in Canada, 2019-2020.
    Wadsworth E; Driezen P; Pacula RL; Hammond D
    Drug Alcohol Depend; 2022 Feb; 231():109262. PubMed ID: 34998249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the public health impacts of legalizing recreational cannabis use in the USA.
    Hall W; Weier M
    Clin Pharmacol Ther; 2015 Jun; 97(6):607-15. PubMed ID: 25777798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.